AAAAAA
Results: 1-25/34
Authors:
Fass, R
Citation: R. Fass, Poorly recognized reflux-induced symptoms, EUR J GASTR, 13, 2001, pp. S32-S34
Authors:
Fass, R
Citation: R. Fass, Testing of diagnosis with a therapeutic trial: concept and requirements for a therapeutic trial, EUR J GASTR, 13, 2001, pp. S49-S50
Authors:
Fass, R
Citation: R. Fass, Outcomes in endoscopy-negative patients after withdrawal of treatment, EUR J GASTR, 13, 2001, pp. S68-S69
Authors:
Fass, R
Malagon, I
Schmulson, M
Citation: R. Fass et al., Chest pain of esophageal origin, CURR OPIN G, 17(4), 2001, pp. 376-380
Authors:
Raisch, DW
Klaurens, LM
Hayden, C
Malagon, I
Pulliam, G
Fass, R
Citation: Dw. Raisch et al., Impact of a formulary change in proton pump inhibitors on health care costs and patients' symptoms, DIG DIS SCI, 46(7), 2001, pp. 1533-1539
Authors:
Lieberman, DA
Weiss, DG
Harford, WV
Ahnen, DJ
Provenzale, D
Sontag, SJ
Schnell, TG
Chejfec, G
Campbell, DR
Durbin, TE
Bond, JH
Nelson, DB
Ewing, SL
Triadafilopoulos, G
Ramirez, FC
Lee, JG
Collins, JF
Fennerty, B
Johnston, TK
Corless, CL
McQuaid, KR
Garewal, H
Sampliner, RE
Morales, TG
Fass, R
Smith, RE
Maheshwari, Y
Citation: Da. Lieberman et al., One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon, N ENG J MED, 345(8), 2001, pp. 555-560
Authors:
Meyer, JH
Lembo, A
Elashoff, JD
Fass, R
Mayer, EA
Citation: Jh. Meyer et al., Duodenal fat intensifies the perception of heartburn, GUT, 49(5), 2001, pp. 624-628
Authors:
Fass, R
Hell, RW
Garewal, HS
Martinez, P
Pulliam, G
Wendel, C
Sampliner, RE
Citation: R. Fass et al., Correlation of oesophageal acid exposure with Barrett's oesophagus length, GUT, 48(3), 2001, pp. 310-313
Authors:
Fass, R
Garewal, HS
Hayden, CW
Ramsey, L
Sampliner, RE
Citation: R. Fass et al., Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus, GASTROIN EN, 53(7), 2001, pp. 711-716
Authors:
Fass, R
Longstreth, GF
Pimentel, M
Fullerton, S
Russak, SM
Chiou, CF
Reyes, E
Crane, P
Eisen, G
McCarberg, B
Ofman, J
Citation: R. Fass et al., Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome, ARCH IN MED, 161(17), 2001, pp. 2081-2088
Authors:
Fass, R
Fennerty, B
Vakil, N
Citation: R. Fass et al., Nonerosive reflux disease - Current concepts and dilemmas, AM J GASTRO, 96(2), 2001, pp. 303-314
Authors:
Benipal, P
Garewal, HS
Sampliner, RE
Martinez, P
Hayden, CW
Fass, R
Citation: P. Benipal et al., Short segment Barrett's esophagus: Relationship of age with extent of intestinal metaplasia, AM J GASTRO, 96(11), 2001, pp. 3084-3088
Authors:
Raziel, A
Landau, O
Fintsi, Y
Fass, R
Charuzi, I
Citation: A. Raziel et al., Sarcoidosis and giant midesophageal diverticulum, DIS ESOPHAG, 13(4), 2000, pp. 317-319
Authors:
Hogan, WJ
Kahrilas, PJ
Fass, R
Kaplan-Machlis, B
Morreale, AP
Citation: Wj. Hogan et al., Efficient and effective treatment of gastroesophageal reflux disease, FORMULARY, 35, 2000, pp. S3-S25
Authors:
Fass, R
Sampliner, RE
Malagon, IB
Hayden, CW
Camargo, L
Wendel, CS
Garewal, HS
Citation: R. Fass et al., Failure of oesophageal acid control in candidates for Barrett's oesophagusreversal on a very high dose of proton pump inhibitor, ALIM PHARM, 14(5), 2000, pp. 597-602
Authors:
Fass, R
Ofman, JJ
Sampliner, RE
Camargo, L
Wendel, C
Fennerty, MB
Citation: R. Fass et al., The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis, ALIM PHARM, 14(4), 2000, pp. 389-396
Authors:
Gerson, LB
Hatton, BN
Ryono, R
Jones, W
Pulliam, G
Sampliner, RE
Triadafilopoulos, G
Fass, R
Citation: Lb. Gerson et al., Clinical and fiscal impact of lansoprazole intolerance in veterans with gastro-oesophageal reflux disease, ALIM PHARM, 14(4), 2000, pp. 397-406
Authors:
Fass, R
Murthy, U
Hayden, CW
Malagon, IB
Pulliam, G
Wendel, C
Kovacs, TOG
Citation: R. Fass et al., Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy - a prospective, randomized, multi-centre study, ALIM PHARM, 14(12), 2000, pp. 1595-1603
Authors:
Fass, R
Citation: R. Fass, Empirical trials in treatment of gastroesophageal reflux disease, DIGEST DIS, 18(1), 2000, pp. 20-26
Authors:
Lieberman, DA
Weiss, DG
Bond, JH
Ahnen, DJ
Garewal, H
Chejfec, G
Harford, WV
Provenzale, D
Sontag, S
Schnell, T
Campbell, DR
Durbin, TE
Nelson, DB
Ewing, SL
Triadafilopoulos, G
Ramirez, FC
Lee, JG
Collins, JF
Fennerty, B
Johnston, TK
Corless, CT
McQuaid, KR
Sampliner, RE
Morales, TG
Fass, R
Smith, R
Maheshwari, Y
Citation: Da. Lieberman et al., Use of colonoscopy to screen asymptomatic adults for colorectal cancer, N ENG J MED, 343(3), 2000, pp. 162-168
Authors:
Fass, R
Sampliner, RE
Citation: R. Fass et Re. Sampliner, Extension of squamous epithelium into the proximal stomach: A newly recognized mucosal abnormality, ENDOSCOPY, 32(1), 2000, pp. 27-32
Authors:
Fass, R
Fullerton, S
Tung, S
Mayer, EA
Citation: R. Fass et al., Sleep disturbances in clinic patients with functional bowel disorders, AM J GASTRO, 95(5), 2000, pp. 1195-1200
Authors:
Fass, R
Pulliam, G
Johnson, C
Garewal, HS
Sampliner, RE
Citation: R. Fass et al., Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux, AGE AGEING, 29(2), 2000, pp. 125-130
Authors:
Fass, R
Citation: R. Fass, Barrett's esophagus: Are Caucasians the only ethnic group at risk?, CANCER DET, 23(2), 1999, pp. 177-178
Authors:
Fass, R
Fennerty, MB
Johnson, C
Camargo, L
Sampliner, RE
Citation: R. Fass et al., Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease, J CLIN GAST, 28(1), 1999, pp. 36-39